Conflicting meta-analytic results: Potential for confusion if left unexplained  by Nijjer, Sukhjinder S. et al.
Letters to the EditorWHY CARDIOTHORACIC
SURGEONS MUST TWEETAND
BLOG
To the Editor:
Health care systems around the
world are under stress and are being
reformed.1 New models of care are re-
quired for a rapidly aging population.
Care that is currently hospital based
must be transferred to the community.
Cardiothoracic surgery provides treat-
ments that may be very effective but
remain very invasive and expensive.
The specialty lags behind general sur-
gery, which has changed dramatically
during the past 10 to 15 years. Many
cardiac treatments, previously under-
taken through open surgery, are now
available with a catheter, carried out
by cardiologists. Although percutane-
ous coronary intervention numbers re-
main stable, numbers of coronary
artery bypass grafting operations, for
many years staple fare for cardiac sur-
geons, are falling precipitously in both
the United States2 and the United
Kingdom. A revolution to reinvigorate
the specialty is required from within
before it is seen to be punching in-
creasingly above its weight.
In the United Kingdom, there is
a communications company that uses
the slogan, ‘‘We’re Better Connected.’’
These 3 words crystallize the trans-
formative potential of social media
to reinvigorate our specialty.
Since the early days of the Internet,
e-mail has been the mainstay of
electronic communication. Protocol
industry changes, referred to as
‘‘web 2.0,’’ have now made the
ability to communicate and share
instantaneously possible. This is
achieved through instant messaging
and social media such as Twitter
and Facebook. Browsers on desktop
computers, smart phones, and touch-
screen tablet devices have inbuilt
sharing capabilities. It is now possible
to share any digital content easily
from any computer or phone or Inter-
net site with like-minded members of
a connected community.The JournalTwitter is a microblogging site3 that
has been embraced by both celebrities
and more significantly the arts and po-
litical classes. Such social media have
radically changed the way business is
done in the arts and politics worlds in
the West. Medicine and particularly
surgery has been late in adopting this
technology. In recent months, medical
educationalists and those who are in-
volved in forming health policy have
had a presence on Twitter. A junior
doctor and a medical student have re-
cently demonstrated the amazing po-
tential of social media by starting the
world’s first Twitter-based journal
club.4 Every Sunday evening, hun-
dreds of medical professionals from
all over the world discuss a nominated
paper. Associations and journals are
also now sharing content on Twitter.5
These are the tools that cardiotho-
racic surgeons around the world must
use to bring about the required trans-
formation. Sharing information from
both within and without the cardiotho-
racic bubble will be key. The instanta-
neous sharing of proceedings from
meetings (not necessarily cardiotho-
racic) with surgeons from all over the
world is nowpossible. It is up to all car-
diothoracic surgeons the world over,
both as individuals and as societies
and associations, to make the effort to
start this global movement. All should
be encouraged to start blogs at free-use
sites such as Blogger, WordPress,
Posterous and Tumblr. The content
should be shared through Twitter or
maybe Facebook. Like-minded folk
will find each other, and soon an online
community with the will to transform
this specialty will be created.
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ANALYTIC RESULTS:
POTENTIAL FOR CONFUSION
IF LEFT UNEXPLAINED
To the Editor:
We read with interest the recent
meta-analysis by Biancari and col-
leagues.1 The use of clopidogrel before
coronary artery bypass grafting re-
mains a controversial issue. Our own
recentmeta-analysis2 used a similar se-
ries of studies but focused specifically
on the effects of acute coronary syn-
drome and case urgency. We showed
that both acute coronary syndrome sta-
tus and urgency influenced mortality
and adverse outcomes. Biancari and
colleagues1 suggested that aggregation
of randomized, controlled trials identi-
fied a reduction in postoperative mor-
tality with preoperative clopidogrel
exposure, whereas observational stud-
ies produced an opposite finding.
They also showed that emergency
cases had a nonsignificant impact
on mortality, which is clinically
unexpected.
Meta-analytic studies may have
conflicts with one another, especially
when study inclusion criteria differ.
Furthermore, there are statistical
methodologic differences worth not-
ing relative to our own study.ry c Volume 143, Number 1 247
Letters to the EditorFirst, we disagree with the exclu-
sion of studies in which the control
subjects had taken clopidogrel until 5
to 7 days before coronary artery by-
pass grafting. This excluded group is
exactly the important group that
must be assessed, because it will con-
tain many patients with recent acute
coronary syndrome, patients with
stent placement, and higher risk pa-
tients requiring ongoing clopidogrel
therapy. Because those undergoing
operation while they are receiving clo-
pidogrel are likely a similar cohort,
inclusion of patients who received
clopidogrel to that point would make
the comparison more valid.
Second, Biancari and colleagues1
predominantly used a fixed-effects
model and only used the random-
effects model when statistical hetero-
geneity was greater than a predefined
cutoff. We believe that a random-
effects model is more appropriate
when reviewing surgical cohorts,
which by their nature have significant
clinical heterogeneity. Furthermore,
nonsignificant results of tests of het-
erogeneity do not guarantee homoge-
neity between studies included in the
meta-analysis, and sources of meth-
odologic or clinical heterogeneity
should be explored.3
The more conservative nature of the
random-effects model provides more
realistic confidence intervals for
groups that can differ wildly between
surgical centers as a result of surgical
experience, the percentage of urgent
cases, and the cornucopia of different
adjunct medical therapies used.
Finally, the debate between fixed-
and random-effects models is not
new. The general consensus remains
that it is unreasonable to assume that
even with adjustment of multiple co-
variates all between-trial variation
can be accounted for, and thus the
random-effects model is preferable.4,5
From a scientific point of view,
reporting the results of both models
allows readers to judge more objec-
tively through sensitivity analysis the
robustness of the meta-analytic248 The Journal of Thoracic and Cfindings. This is particularly relevant
when the fixed-effects model for post-
operative death demonstrates a lower
95% confidence interval, just margin-
ally above the1-null effect.On reassess-
ment with a random-effects model,
we find that their effect size becomes
statistically nonsignificant, with risk
ratio of 1.28 (95% confidence interval,
0.99–1.66).
The findings regarding reduced
postoperative myocardial infarction
and increased blood product use and
reoperation remain valid.
Although the statistical change in
mortality may appear small, it re-
flects the importance of appropriate
methodologic rigor and accurate re-
porting. The original choice of model
may have been influenced by the P
value generated.
We conclude that with a change in
the statistical model from fixed to
random effects, the conclusion of
Biancari and colleages1 that observa-
tional studies show significantly
increased mortality no longer holds
true.
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On the basis of their own recent
meta-analysis on this topic,1 Nijjer
and colleagues commented on the
results of our meta-analysis about the
effects of preoperative exposure to
clopidogrel before coronary artery by-
pass grafting.2 Nijjer and colleagues
raised concerns regarding our meth-
odology, which could have affected
the results of our meta-analysis. In
our study, we used a fixed-effects
model when heterogeneity was con-
sidered unimportant. We do agree
with Nijjer and colleagues that a ran-
dom-effects model is more appropri-
ate when analyzing nonrandomized
studies. In fact, we used the latter
method in our most recent meta-
analyses. Here, we report the results
of using a random-effects model in
all outcome end points (Table 1).
The use of this method provided sim-
ilar results to those published, but ac-
cording to random-effects analysis,
the increased risk of immediate
postoperative mortality for patients
exposed to clopidogrel only tended
to be significant (risk ratio, 1.28;
95% confidence interval, 0.99–1.66;
P ¼ .06).
Nijjer and colleagues disagreed
about our decision to exclude from
the analysis those studies including
control subjects exposed to clopidog-
rel for whom the drug was discontin-
ued 5 to 7 days before surgery. Even
if Nijjer and colleagues argue that
these control subjects would include
